LAYLA BENHAM: Open Payments
NPI 1134882889 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$218 in 11 payments from 9 companies in 2025. Trend: 2023 $37 · 2024 $119 · 2025 $218
Food & beverage: $218
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $51 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| Averitas Pharma Inc. | 1 | $28 |
| SI-BONE, INC. | 1 | $25 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $22 |
| Valinor Pharma, LLC | 1 | $16 |
| Boston Scientific Corporation | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
| BIOTRONIK NRO, Inc. | 1 | $14 |
Products named: BOTOX, RELISTOR, QUTENZA, JOURNAVX, MOVANTIK, Intracept, FANAPT, Prospera.
Industry payments across KY — which companies pay providers there.
